DUBLIN (AP) — DUBLIN (AP) — Prothena Corp. (PRTA) on Thursday reported a loss of $60.2 million in its first quarter. The Dublin-based company said it had a loss of $1.12 per share. The results ...

DUBLIN, May 01, 2025--(BUSINESS WIRE)--Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein ...

"We continue to meaningfully advance our wholly-owned and partnered programs across our protein dysregulation portfolio during this transformative year for Prothena. Most notably in 2025 we ...

DUBLIN, May 01, 2025--(BUSINESS WIRE)--Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein ...

In the last three months, 7 analysts have published ratings on Prothena Corp PRTA, offering a diverse range of perspectives from bullish to bearish. The table below provides a snapshot of their ...